Huntington National Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-222
Closed -$40K 2299
2021
Q2
$40K Hold
222
﹤0.01% 1022
2021
Q1
$34K Buy
222
+89
+67% +$13.6K ﹤0.01% 963
2020
Q4
$21K Buy
133
+59
+80% +$9.32K ﹤0.01% 1119
2020
Q3
$8K Hold
74
﹤0.01% 1278
2020
Q2
$8K Sell
74
-873
-92% -$94.4K ﹤0.01% 1260
2020
Q1
$84K Buy
947
+34
+4% +$3.02K ﹤0.01% 642
2019
Q4
$98K Buy
913
+340
+59% +$36.5K ﹤0.01% 712
2019
Q3
$55K Sell
573
-1,091
-66% -$105K ﹤0.01% 816
2019
Q2
$217K Sell
1,664
-305
-15% -$39.8K ﹤0.01% 494
2019
Q1
$265K Buy
1,969
+1,827
+1,287% +$246K ﹤0.01% 475
2018
Q4
$14K Sell
142
-180
-56% -$17.7K ﹤0.01% 1232
2018
Q3
$45K Buy
322
+24
+8% +$3.35K ﹤0.01% 1002
2018
Q2
$37K Sell
298
-3
-1% -$372 ﹤0.01% 1055
2018
Q1
$34K Sell
301
-589
-66% -$66.5K ﹤0.01% 1078
2017
Q4
$106K Sell
890
-154
-15% -$18.3K ﹤0.01% 753
2017
Q3
$146K Sell
1,044
-34
-3% -$4.76K ﹤0.01% 656
2017
Q2
$131K Buy
1,078
+987
+1,085% +$120K ﹤0.01% 669
2017
Q1
$11K Sell
91
-194
-68% -$23.5K ﹤0.01% 1159
2016
Q4
$35K Sell
285
-7
-2% -$860 ﹤0.01% 997
2016
Q3
$36K Buy
292
+14
+5% +$1.73K ﹤0.01% 997
2016
Q2
$32K Sell
278
-282
-50% -$32.5K ﹤0.01% 1022
2016
Q1
$97K Sell
560
-47
-8% -$8.14K ﹤0.01% 924
2015
Q4
$115K Buy
607
+25
+4% +$4.74K ﹤0.01% 775
2015
Q3
$91K Sell
582
-3
-0.5% -$469 ﹤0.01% 889
2015
Q2
$105K Buy
585
+25
+4% +$4.49K ﹤0.01% 900
2015
Q1
$97K Buy
560
+39
+7% +$6.76K ﹤0.01% 927
2014
Q4
$96K Sell
521
-781
-60% -$144K ﹤0.01% 935
2014
Q3
$216K Sell
1,302
-182
-12% -$30.2K ﹤0.01% 932
2014
Q2
$232K Sell
1,484
-1,153
-44% -$180K ﹤0.01% 982
2014
Q1
$401K Buy
2,637
+2,329
+756% +$354K 0.01% 873
2013
Q4
$41K Sell
308
-2
-0.6% -$266 ﹤0.01% 1153
2013
Q3
$36K Sell
310
-30
-9% -$3.48K ﹤0.01% 1162
2013
Q2
$31K Buy
+340
New +$31K ﹤0.01% 1184